Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 71205-731

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 71205-731). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

71205-731-30 (Atorvastatin 40 mg 30 Bottle Label)

Label for Atorvastatin Calcium 40 mg film-coated tablets, containing 30 tablets per package. The label states each tablet contains Atorvastatin Calcium USP equivalent to 40 mg Atorvastatin. It is manufactured by Intas Pharmaceuticals Limited, Ahmedabad, India, and labeled by Proficient Rx LP. The label includes storage instructions and multiple barcodes and QR codes.*

FDA Label Image

Figure (Atorvastatin Calcium Figure 1)

A line graph showing cumulative incidence percentage over time in years, comparing Atorvastatin and placebo groups. The graph illustrates lower cumulative incidence for Atorvastatin with a hazard ratio of 0.64 (95% CI, 0.50-0.83) and a p-value of 0.0005, indicating statistical significance.*

FDA Label Image

Figure (Atorvastatin Calcium Figure 2)

A cumulative hazard graph comparing Atorvastatin versus placebo over 5 years. The x-axis represents time to first primary endpoint in years, and the y-axis shows cumulative hazard percentage. The graph includes hazard ratio (HR=0.63) and a p-value (p=0.001), indicating lower cumulative hazard with Atorvastatin compared to placebo.*

FDA Label Image

Figure (Atorvastatin Calcium Figure 3)

A line graph comparing the percentage of subjects experiencing a major cardiovascular event over five years between Atorvastatin 10 mg (dashed line) and Atorvastatin 80 mg (solid line). The X-axis shows time in years to first major cardiovascular endpoint, and the Y-axis shows the percentage of subjects experiencing the event. The graph includes a hazard ratio (HR) of 0.78 with a confidence interval of 0.69-0.89 and a p-value of 0.0002, indicating statistical data between the two dosage groups.*

FDA Label Image

Chemical Structure (Atorvastatin Calcium Structure)

Chemical structure diagram of atorvastatin calcium, showing its molecular arrangement including functional groups and calcium ions with hydration, corresponding to the active ingredient atorvastatin calcium.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.